* Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected to show a
rise in quarterly revenue when it reports results on May 11 .
* The Irvine, California-based company is expected to report a
5.1% increase in revenue to $3.274 million from $3.12 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Clearpoint Neuro Inc is
for a loss of 14 cents per share. For the same quarter last
year, the company reported a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 62.5% in the last three months.
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $35, about 45.9% above its last closing price
of $18.94.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 -0.13 -0.13 -0.09 Beat 30.8
Sep. 30 2020 -0.14 -0.14 -0.09 Beat 35.7
Jun. 30 2020 -0.16 -0.16 -0.11 Beat 31.3
Mar. 31 2020 -0.18 -0.18 -0.13 Beat 27.8
This summary was machine generated May 8 at 00:50 GMT. All
figures in US dollars unless otherwise stated